| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |